According to the Catalogue of Somatic Mutations in Cancer (COSMIC) database (version 62), the AKT1 E17K hotspot mutation is present in approximately 4% of breast tumors, 2.5% of endometrial cancers and 0.3% of ovarian cancers [9]. This evidence concerns the gene AKT1 and breast neoplasm.